药物临床试验违背方案影响因素模型构建
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

安徽省中医药管理局中医药传承创新科研项目(中医药课题)“金雀根治疗类风湿关节炎的作用及分子机制研究”(2020cczd05)


Construction of a model of influencing factors of illegal events in drug clinical trials
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    为深入探究影响药物临床试验违背方案发生的因素,以扎根理论为基础对安徽省某大型综合医院2017—2019年药物临床试验违背方案记录进行整理分析,构建药物临床试验违背方案影响因素模型。结果显示,“药物临床试验风险预控”与“药物临床试验前提基础”对违背方案的发生存在显著影响。建议提升研究环境资源条件,加强研究者及研究团队相关培训,合理设计研究方案。建立安全监测系统,完善不良事件报告处理机制,引导研究人员道德伦理意识观念深层转变,为减少临床试验违背方案的发生,控制药物临床试验质量提供一定的思路和建议。

    Abstract:

    In order to deeply explore the factors that affect the occurrence of illegal events in drug clinical trials, this study used the grounded theory to sort out and analyze the illegal records of drug clinical trials during 2017—2019 in a large general hospital in Anhui Province and construct a model of influencing factors of illegal events in drug clinical trials. The results showed that “pre?control of drug clinical trial risks” and “prerequisite basis for drug clinical trials” had significant impact on the occurrence of plan violations. It is recommended to improve the research environment and resource conditions, strengthen the relevant training of researchers and research teams, and rationally design research plans. It is suggested to establish a safety monitoring system, improve the reporting and handling mechanism for adverse events, guide researchers to deepen the transformation of moral concepts, and provide some ideas and suggestions for reducing the occurrence of illegal events in clinical trials and controlling the quality of drug clinical trials.

    参考文献
    相似文献
    引证文献
引用本文

陈仙萍,张 静,汪卓赟,鲁 超.药物临床试验违背方案影响因素模型构建[J].南京医科大学学报(社会科学版),2021,(4):361~365

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2021-04-19
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-09-06
  • 出版日期:
文章二维码